@article{2edc69a7a27f43ada60a961554200b28,
title = "To immunosuppress: Whom, when and how? That is the question with COVID-19",
keywords = "arthritis, biological therapy, glucocorticoids, rheumatoid",
author = "Winthrop, {Kevin L.} and Xavier Mariette",
note = "Funding Information: Competing interests KLW reports personal fees from Pfizer, AbbVie, Union Chimique Belge (UCB), Eli Lilly & Company, Galapagos, GlaxoSmithKline (GSK), Roche, and Gilead and reports research grants from BMS, Pfizer, outside the submitted work.",
year = "2020",
month = sep,
day = "1",
doi = "10.1136/annrheumdis-2020-218694",
language = "English (US)",
volume = "79",
pages = "1129--1131",
journal = "Annals of the rheumatic diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "9",
}